Literature DB >> 27267061

A novel role of c-FLIP protein in regulation of ER stress response.

Silvia Conti1, Simonetta Petrungaro1, Elettra Sara Marini2, Silvia Masciarelli1, Luana Tomaipitinca1, Antonio Filippini1, Claudia Giampietri1, Elio Ziparo3.   

Abstract

Cellular-Flice-like inhibitory protein (c-FLIP) is an apoptosis modulator known to inhibit the extrinsic apoptotic pathway thus blocking Caspase-8 processing in the Death Inducing Signalling Complex (DISC). We previously demonstrated that c-FLIP localizes at the endoplasmic reticulum (ER) and that c-FLIP-deficient mouse embryonic fibroblasts (MEFs) display an enlarged ER morphology. In the present study, we have addressed the consequences of c-FLIP ablation in the ER stress response by investigating the effects of pharmacologically-induced ER stress in Wild Type (WT) and c-FLIP-/- MEFs. Surprisingly, c-FLIP-/- MEFs were found to be strikingly more resistant than WT MEFs to ER stress-mediated apoptosis. Analysis of Unfolded Protein Response (UPR) pathways revealed that Pancreatic ER Kinase (PERK) and Inositol-Requiring Enzyme 1 (IRE1) branch signalling is compromised in c-FLIP-/- cells when compared with WT cells. We found that c-FLIP modulates the PERK pathway by interfering with the activity of the serine threonine kinase AKT. Indeed, c-FLIP-/- MEFs display higher levels of active AKT than WT MEFs upon ER stress, while treatment with a specific AKT inhibitor of c-FLIP-/- MEFs subjected to ER stress restores the PERK but not the IRE1 pathway. Importantly, the AKT inhibitor or dominant negative AKT transfection sensitizes c-FLIP-/- cells to ER stress-induced cell death while the expression of a constitutively active AKT reduces WT cells sensitivity to ER stress-induced death. Thus, our results demonstrate that c-FLIP modulation of AKT activity is crucial in controlling PERK signalling and sensitivity to ER stress, and highlight c-FLIP as a novel molecular player in PERK and IRE1-mediated ER stress response.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Endoplasmic reticulum stress; Mouse embryonic fibroblast; UPR; c-FLIP

Mesh:

Substances:

Year:  2016        PMID: 27267061     DOI: 10.1016/j.cellsig.2016.06.003

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  5 in total

1.  Expression of ERO1L in gastric cancer and its association with patient prognosis.

Authors:  Bo Zhou; Gongping Wang; Shegan Gao; Ye Chen; Canhui Jin; Zengfang Wang; Yantong Yang; Zhikun Ma; Wei Zhang; Xiaoshan Feng
Journal:  Exp Ther Med       Date:  2017-07-11       Impact factor: 2.447

2.  TAS4464, a NEDD8-activating enzyme inhibitor, activates both intrinsic and extrinsic apoptotic pathways via c-Myc-mediated regulation in acute myeloid leukemia.

Authors:  Hiroaki Ochiiwa; Guzhanuer Ailiken; Masataka Yokoyama; Kazuyuki Yamagata; Hidekazu Nagano; Chihoko Yoshimura; Hiromi Muraoka; Keiji Ishida; Tomonori Haruma; Akitoshi Nakayama; Naoko Hashimoto; Kazutaka Murata; Motoi Nishimura; Yusuke Kawashima; Osamu Ohara; Shuichi Ohkubo; Tomoaki Tanaka
Journal:  Oncogene       Date:  2021-01-08       Impact factor: 9.867

Review 3.  FLIP(L): the pseudo-caspase.

Authors:  Peter Smyth; Tamas Sessler; Christopher J Scott; Daniel B Longley
Journal:  FEBS J       Date:  2020-03-12       Impact factor: 5.542

4.  c-FLIP regulates autophagy by interacting with Beclin-1 and influencing its stability.

Authors:  Luana Tomaipitinca; Simonetta Petrungaro; Pasquale D'Acunzo; Angelo Facchiano; Amit Dubey; Salvatore Rizza; Federico Giulitti; Eugenio Gaudio; Antonio Filippini; Elio Ziparo; Francesco Cecconi; Claudia Giampietri
Journal:  Cell Death Dis       Date:  2021-07-08       Impact factor: 8.469

5.  cFLIP downregulation is an early event required for endoplasmic reticulum stress-induced apoptosis in tumor cells.

Authors:  Rocío Mora-Molina; Daniela Stöhr; Markus Rehm; Abelardo López-Rivas
Journal:  Cell Death Dis       Date:  2022-02-03       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.